Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Alteplase for Lower Extremity DVT
NCT00082355Phase 2Completed
- Start
- May 2004
- Primary completion
- Mar 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tissue-plasminogen activator in deep vein thrombosis (DVT). Primary endpoint: Number of Participants With Restored Venous Function at 6 months. Started May 2004; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00082355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082355.